Related Experiment Videos
Hepatitis C
M J Alter1, E E Mast, L A Moyer
1Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Insights
Hepatitis C virus (HCV) causes chronic liver disease globally, with persistent infection often linked to weak immune responses. Injection drug use remains the primary driver of HCV transmission, yet public health efforts lag behind clinical advancements.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) is a significant global cause of chronic liver disease.
- Persistent HCV infection is common, often due to an inadequate neutralizing immune response.
- Viral genetic diversity and host factors influence HCV's endemicity.
Purpose of the Study:
- To highlight the factors contributing to the widespread prevalence of HCV infection.
- To emphasize the critical role of injection drug use in HCV transmission.
- To underscore the gap between clinical advancements and public health awareness/resource allocation for HCV.
Main Methods:
- Review of epidemiological data on HCV transmission.
- Analysis of factors influencing viral persistence and host immune response.
- Assessment of public health strategies and resource allocation for HCV prevention and treatment.
Main Results:
- Injection drug use is identified as the leading risk factor for HCV transmission in developed countries.
- The majority of HCV infections become persistent, linked to immune evasion.
- Despite clinical progress, public health awareness and resources for HCV remain insufficient.
Conclusions:
- Effective public health strategies must address injection drug use to curb HCV transmission.
- Increased resources are crucial for comprehensive HCV prevention and treatment programs.
- Bridging the gap between clinical knowledge and public health action is vital for controlling the HCV epidemic.
Abstract:
Hepatitis C virus (HCV) has emerged as a major cause of chronic liver disease worldwide. The widespread endemicity of HCV infection is the result of a combination of factors, including those related to the genetic diversity of the virus and the host response and those related to the specific settings and behaviors that have facilitated transmission. Most people who contract HCV infection become persistently infected, and the mechanism by which persistent infection is established seems to be related to the lack of development of an effective neutralizing immune response. The magnitude of the spread of HCV infection primarily is related to specific risk factors for transmission. The most important human behavior related to the transmission of HCV has been injection drug use, which in many developed countries has been the leading source of HCV infection during the past 20 to 30 years. The recognition of the clinical importance of HCV infection has resulted in a substantial amount of attention and resources rapidly directed toward developing new and improved therapies. The perception, however, of the public health importance of HCV infection is still limited. Despite the knowledge that injection drug use is the major source of HCV infection in the United States, this message has not been included in prevention and treatment programs, and the resources needed to support strong public health programs have yet to be identified.